Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes (2016 - 2018)

China Pharma Holdings (CPHI) has disclosed Deferred Taxes for 9 consecutive years, with -$1195.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Deferred Taxes fell 103.91% year-over-year to -$1195.0, compared with a TTM value of $68419.0 through Dec 2018, down 44.21%, and an annual FY2018 reading of $68419.0, down 44.21% over the prior year.
  • Deferred Taxes was -$1195.0 for Q4 2018 at China Pharma Holdings, down from $21039.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $421825.0 in Q3 2015 and bottomed at -$1195.0 in Q4 2018.
  • Average Deferred Taxes over 5 years is $60735.0, with a median of $21814.5 recorded in 2018.
  • The sharpest move saw Deferred Taxes skyrocketed 2095.29% in 2015, then plummeted 103.91% in 2018.
  • Year by year, Deferred Taxes stood at $19284.0 in 2014, then surged by 2087.44% to $421825.0 in 2015, then tumbled by 42.36% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then plummeted by 103.91% to -$1195.0 in 2018.
  • Business Quant data shows Deferred Taxes for CPHI at -$1195.0 in Q4 2018, $21039.0 in Q3 2018, and $22590.0 in Q2 2018.